Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic method of quinoxaline pharmaceutical intermediate compound

A synthesis method and compound technology, which are applied in the synthesis of nitrogen-containing fused ring compounds and the synthesis of quinoxaline pharmaceutical intermediate compounds, can solve the problems of poor atom economy, insufficient substrate sources, and unsatisfactory yields. Achieve the effects of high yield, good industrial application prospect and potential

Inactive Publication Date: 2016-08-24
李强
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] As mentioned above, although there are many synthetic methods of quinoxaline compounds in the prior art, these methods have the disadvantages of poor atom economy, unsatisfactory yield and insufficient substrate sources.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of quinoxaline pharmaceutical intermediate compound
  • A kind of synthetic method of quinoxaline pharmaceutical intermediate compound
  • A kind of synthetic method of quinoxaline pharmaceutical intermediate compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1: Synthesis of 6-chloro-2,3-diphenylquinoxaline

[0045]

[0046] In 400ml DMSO, add 100mmol of formula (II) compound, 100mmol of formula (III) compound (1,2-dibromo-1,2-diphenylethane), 1mmol dichlorodiammine platinum, 1.5mmol 4, 7-Dimethyl-1,10-phenanthroline, 200mmol of diisopropanolamine and 10mmol of N-hexylpyridine hexafluorophosphate, and then nitrogen purge twice to make the reaction atmosphere a nitrogen atmosphere; the reaction system from room temperature The temperature was raised to 80°C, and the reaction was stirred at this temperature for 12 hours.

[0047] After the reaction, the reaction system was naturally cooled to room temperature, and then washed with saturated brine. The camera was separated and the organic phase was concentrated in vacuo. The residue was subjected to 200 mesh silica gel column chromatography using petroleum ether and chloroform in a volume ratio of 2:1 As the eluent, the target compound of formula (I) 6-chloro-2,3-diphenylqu...

Embodiment 2

[0051] Example 2: Synthesis of 6-Methoxyquinoxaline

[0052]

[0053] In 400ml NMP, add 100mmol of formula (II) compound, 150mmol of formula (III) compound (1,2-dibromoethane), 3mmol dichlorodiammine platinum, 6mmol 4,7-dimethyl-1,10 -Phenanthroline, 250mmol diisopropanolamine and 20mmol N-hexylpyridine hexafluorophosphate, and then nitrogen purge twice to make the reaction atmosphere a nitrogen atmosphere; the reaction system is raised from room temperature to 100°C, and The reaction was stirred at temperature for 10 hours.

[0054] After the reaction, the reaction system was naturally cooled to room temperature, and then washed with saturated brine. The camera was separated and the organic phase was concentrated in vacuo. The residue was subjected to 200-mesh silica gel column chromatography using petroleum ether and chloroform in a volume ratio of 3:1 As the eluent, the target compound of formula (I) 6-methoxyquinoxaline was obtained with a yield of 98.4%.

[0055] 1 H-NMR (400M...

Embodiment 3

[0057] Example 3: Synthesis of 6,7-dimethyl-2-phenylquinoxaline

[0058]

[0059] In 400ml of toluene, add 100mmol of formula (II) compound, 200mmol of formula (III) compound (1,2-dibromoethylbenzene), 5mmol dichlorodiammine platinum, 12mmol 4,7-dimethyl-1, 10-phenanthroline, 300mmol diisopropanolamine and 30mmol N-hexylpyridine hexafluorophosphate, and then nitrogen purge twice to make the reaction atmosphere a nitrogen atmosphere; the reaction system was raised from room temperature to 120 ℃, and The reaction was stirred at this temperature for 8 hours.

[0060] After the reaction, the reaction system was naturally cooled to room temperature, and then washed with saturated brine. The camera was separated and the organic phase was concentrated in vacuo. The residue was subjected to 200 mesh silica gel column chromatography using petroleum ether and chloroform in a volume ratio of 4:1 As the eluent, the target compound of formula (I) 6,7-dimethyl-2-phenylquinoxaline was obtained w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a synthetic method for a quinoxaline medical intermediate compound as shown in formula (I). The quinoxaline medical intermediate compound synthetic method includes reacting a compound of formula (II) and a compound of formula (III) in an organic solvent in the presence of a catalyst, an organic ligand, an alkali, and an accelerant in an inert atmosphere so as to obtain the compound of formula (I), wherein R1 and R2 are respectively independently selected from H, halogen, C1-C6 alkyl or C1-C6 alkoxy, R3 and R4 are respectively independently selected from H, C1-C6 alkyl, C1-C6 alkoxy or phenyl, and each X independently represents halogen. According to the synthetic method for the quinoxaline medical intermediate compound, by means of selection and mutual synergy of the suitable catalyst, the organic ligand, the alkali and the accelerant, a target product is obtained at a high yield, and a good industrialized prospect and an application potential are achieved.

Description

Technical field [0001] The invention relates to a method for synthesizing a nitrogen-containing fused ring compound, more specifically to a method for synthesizing a quinoxaline pharmaceutical intermediate compound, and belongs to the field of organic chemical synthesis and pharmaceutical intermediates. Background technique [0002] In the fields of organic chemistry and pharmaceutical synthesis, quinoxaline structural units can be used to construct an important class of nitrogen-containing heterocyclic compounds, which have a variety of biological activities, such as anti-tumor, anti-convulsant, anti-bacterial, anti-inflammatory, anti-HIV and Anti-cancer activity, etc. Therefore, the quinoxaline structural unit, as a key module in the construction of drugs, has received widespread attention from the majority of medical workers, and the study of the preparation process of quinoxaline compounds has increasingly become a key problem for researchers to solve. [0003] So far, a varie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D241/42
CPCC07D241/42
Inventor 李强于宗学王晋军陈啸
Owner 李强